Harrow, Inc. is a leading eyecare pharmaceutical company focused on the discovery, development, and commercialization of innovative ophthalmic products for the U.S. market. They are dedicated to making medications more accessible and affordable, partnering with eyecare professionals to provide a diverse portfolio of high-quality products for various eye conditions and surgeries.
VIViridian Therapeutics is a biopharmaceutical company dedicated to developing innovative treatments for rare autoimmune conditions.
Regeneron Pharmaceuticals is a leading biotechnology company dedicated to innovating life-changing medicines for serious diseases through proprietary scientific technologies.
XIXeris Pharmaceuticals, Inc. is a biotechnology company that specializes in developing innovative therapeutic solutions for patients requiring chronic care.
Apellis Pharmaceuticals is a biopharmaceutical company specializing in targeted therapies for diseases impacted by the complement system.
TITarsus Pharmaceuticals, Inc. is a biopharmaceutical company dedicated to advancing innovative therapies for diseases with significant unmet needs, focusing on eye care.